These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25386935)

  • 1. T cell-mediated hypersensitivity reactions to drugs.
    Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
    Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA and Delayed Drug-Induced Hypersensitivity.
    Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
    Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
    Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
    J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping for severe drug hypersensitivity.
    Karlin E; Phillips E
    Curr Allergy Asthma Rep; 2014 Mar; 14(3):418. PubMed ID: 24429903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
    White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
    Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
    J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.
    Illing PT; Mifsud NA; Purcell AW
    Curr Opin Immunol; 2016 Oct; 42():31-40. PubMed ID: 27261882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and pharmacogenetics of drug hypersensitivity.
    Pavlos R; Mallal S; Phillips E
    Pharmacogenomics; 2012 Aug; 13(11):1285-306. PubMed ID: 22920398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
    Ko TM; Chen YT
    Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity.
    Guéant JL; Guéant-Rodriguez RM; Gastin IA; Cornejo-García JA; Viola M; Barbaud A; Mertes PM; Blanca M; Romano A
    Curr Pharm Des; 2008; 14(27):2770-7. PubMed ID: 18991696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
    Michels AW; Ostrov DA
    J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
    Pirmohamed M; Ostrov DA; Park BK
    J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.